For media relations inquiries, please contact
Media_MTPA@mt-pharma-us.com
We know that collaboration and an open exchange of ideas are important to developing effective new treatments. Our Medical Affairs team works with scientific communities in the U.S. to share knowledge and facilitate educational and research programs.
Mitsubishi Tanabe Pharma America’s acceptance of a funding request is dependent upon multiple factors including, but not limited to, scientific merit, company goals, and availability of resources/funding.
Learn MoreMTPA will register and disclose information on publicly accessible clinical trial registries such as ClinicalTrials.gov regarding clinical trials that are being conducted or have been conducted.
MTPA will disclose the results from clinical trials in patients that form part of the submission package for products approved in the United States. Results will not be disclosed if MTPA decides that disclosure may lead to identification of clinical trial participants. Results may not be disclosed under any of the following conditions: